NNVC is trading 8.2% down at $1.24 in pre-market, extending a mild pullback after a strong multi-month run and recent high volatility.
- No fresh company-specific headlines, earnings, FDA decisions, or analyst actions were reported overnight.
- The move appears to be normal volatility in a thinly traded, highly speculative biotech stock rather than a reaction to new news.